| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €11,3578 | -0,12% | €727,74M | €1,46M | |
| €41,2734 | +0,00% | €727,31M | €95,14K | |
| €17,2906 | +0,00% | €726,26M | €339,65K | |
EVC Entravision Communication | €7,3780 | -3,08% | €725,40M | €1,31M | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €25,3196 | +0,14% | €723,99M | €177,43K | |
| €23,6660 | -0,02% | €722,37M | €148,02K | |
AMPH Amphastar Pharmaceuticals, Inc. | €17,1343 | +0,00% | €721,43M | €574,08K | |
MATW Matthews International Corp | €21,9951 | -0,04% | €718,80M | €154,29K | |
TBPH Theravance Biopharma, Inc. | €14,1484 | +0,06% | €718,65M | €161,46K | |
MPB Mid Penn Bancorp, Inc. | €28,4791 | -0,15% | €718,28M | €81,13K | |
KRO Kronos Worldwide, Inc. | €5,5812 | +0,00% | €718,03M | €158,19K | |
ADAM Adamas Trust, Inc. Common Stock | €7,7946 | +0,00% | €717,59M | €272,11K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €19,1828 | +0,00% | €716,01M | €37,29K | |
ROOT Root, Inc. Class A Common Stock | €46,4467 | -0,06% | €715,15M | €191,18K | |
EOI Eaton Vance Enhanced Equity Income Fund | €16,9086 | +0,00% | €714,63M | €92,99K | |
